| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $179.2M | -2.0% |
| SG&A Expense | $47.0M | +28.8% |
| Operating Income | -$248.0M | -9.3% |
| Income Tax | $0 | — |
| Net Income | -$241.3M | -6.4% |
| EPS (Basic) | -$2.23 | +58.1% |
| EPS (Diluted) | -$2.23 | +58.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.1M | -83.0% |
| Current Assets | $376.9M | -38.9% |
| Total Assets | $383.2M | -38.2% |
| Current Liabilities | $25.0M | -59.7% |
| Total Liabilities | $27.2M | -56.2% |
| Stockholders' Equity | $356.0M | -36.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$220.0M | -19.1% |
| Capital Expenditures | $1.7M | +1929.8% |
| Investing Cash Flow | -$230.7M | -354.9% |
| Financing Cash Flow | $506K | -99.9% |
| Free Cash Flow | -$221.7M | -20.0% |